Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus

• Alessandra Vitelli,

  Affiliation Okairòs, Rome, Italy

  ⨯
• Mary R. Quirion,

  Affiliation Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Chia-Yun Lo,

  Affiliation Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Julia A. Misplon,

  Affiliation Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Agnieszka K. Grabowska,

  Current address: German Cancer Research Center, Immunotherapy and Prevention, Heidelberg, Germany

  Affiliation Okairòs, Rome, Italy

  ⨯
• Angiolo Pierantoni,

  Affiliation Okairòs, Rome, Italy

  ⨯
• Virginia Ammendola,

  Affiliation Okairòs, Rome, Italy

  ⨯
• Graeme E. Price,

  Affiliation Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Mark R. Soboleski,

  Current address: Center for Devices and Radiological Health, Food and Drug Administration, White Oak, Maryland, United States of America

  Affiliation Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯
• Riccardo Cortese,

  Affiliation Okairòs, Rome, Italy

  ⨯
• Stefano Colloca,

  Affiliation Okairòs, Rome, Italy

  ⨯
• Alfredo Nicosia,

  Affiliations Okairòs, Rome, Italy, Centro di Ingegneria Genetica e Biotecnologia Avanzate (CEINGE), Naples, Italy, Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Naples, Italy

  ⨯
• Suzanne L. Epstein

  * E-mail: suzanne.epstein@fda.hhs.gov

  Affiliation Gene Therapy and Immunogenicity Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America

  ⨯